Cyclin L1 and Lymph Node Metastases in Head and Neck Cancer
Author Information
Author(s): Sticht C, Hofele C, Flechtenmacher C, Bosch F X, Freier K, Lichter P, Joos S
Primary Institution: Universitätsklinikum Heidelberg
Hypothesis
Is there an association between Cyclin L1 amplification and lymph node metastases in head and neck squamous cell carcinoma?
Conclusion
The study found that Cyclin L1 amplification is significantly associated with lymph node metastases and shorter overall survival in head and neck squamous cell carcinoma.
Supporting Evidence
- CCNL1 gains were found in 34.3% of HNSCC cases.
- High-level amplifications of CCNL1 correlated with shorter overall survival.
- CCNL1 gains were more frequent in stage IV tumors compared to earlier stages.
Takeaway
This study shows that a gene called Cyclin L1 can help doctors understand if a head and neck cancer might spread to other parts of the body.
Methodology
Tissue microarray analysis was performed on 280 HNSCC samples using fluorescence in situ hybridization to assess copy number gains of several oncogenes.
Limitations
The study's findings regarding high-level amplifications of CCNL1 were based on a low number of cases, limiting the robustness of the conclusions.
Participant Demographics
The study included 280 patients with head and neck squamous cell carcinoma, with specific subgroups for oral, pharyngeal, and laryngeal cancers.
Statistical Information
P-Value
0.049
Statistical Significance
p=0.049
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website